The Valley Desk

NCT00078338 · Interventional trial

Rebif® Versus Copaxone® in the Treatment of Relapsing Remitting Multiple Sclerosis

Overall registry status Completed

Phase 4

Conditions Relapsing-remitting Multiple Sclerosis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov